Revenue from operations₹2,229.40 Cr
JUBLPHARMA · What Changed
What Changed at
Jubilant Pharmova Limited?
See reported financial changes and material NSE disclosures for Jubilant Pharmova Limited.
My CompaniesSaved on this device. No account needed.
Follow a company to build your personal change feed.
Latest company changes
Jubilant Pharmova Limited
Start with what changed, then open the supporting financial and operating detail only when you need it.
JUBLPHARMA · Consolidated
Jubilant Pharmova Limited
Latest reported period
Latest reported changes
What Actually Changed
Worth reviewingNeutral / mixedNSE disclosure · 14 Oct 2026CreditThe company disclosed credit Rating Credit Rating.
+
Worth reviewingNeutral / mixedNSE disclosure · 12 Oct 2026CapitalThe company disclosed issuance of securities Alteration Of Capital and Fund Ra.
+
Worth reviewingNeutral / mixedNSE disclosure · 12 Oct 2026CapitalThe company disclosed issuance of Secured / Unsecured.
+
Financial snapshot
Latest Reported Financials
Available reported figures from the latest period.
Total income₹2,249.30 Cr
Profit after tax₹56.40 Cr
EPS₹3.56
Profit before tax₹86.40 Cr
Supporting financial context
Margins and Supporting Figures
Only reported or directly calculated figures that are available for this company.
PAT margin2.53%
Profit before tax₹86.40 Cr
Finance cost₹54.20 Cr
Depreciation₹127.30 Cr
Tax₹30.00 Cr
Other income₹19.90 Cr
Today
Loading today’s changes…Today on Nivata
— meaningful changes— companies
Checking the latest tracked company developments…